NCT06249919: A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients |
|
|
| Recruiting | 1/2 | 118 | RoW | NS101, Placebo | Neuracle Science Co., LTD., Severance Hospital, Samsung Medical Center, Korea University Anam Hospital | Seneorineural Deafness, Sudden Sensorineural Hearing Loss | 06/25 | 06/25 | | |